Literature DB >> 33840181

Recovering of oxygenation, physical function and disability in patients with Covid-19.

Laura Bertacchini1, Mara Paneroni2, Laura Comini3, Simonetta Scalvini4, Michele Vitacca5.   

Abstract

The present case report describes middle-time course of respiratory and physical variables in eight Covid-19 patients who were transferred from ICU of Covid Hub in our subacute Covid-19 unit. Secondly they were admitted in a pulmonary rehabilitation unit and, at discharge, a tele-rehabilitation program was provided as a continuum of care at home. Time course of oxygenation, physical function and disability were recorded. As expected, the acute event produced in these patients a dramatic worsening in oxygenation and physical activities, with a substantial improvement in oxygenation and mild disability after the sub-acute stay. After rehabilitation program, the patients showed additional improvement in particular in physical function. Anyway, this recover was not complete for all patients. The majority of Covid-19 survivors experienced ARF recovered oxygenation, physical function and disability within a median time of 137 days. A minority needs further follow up and rehabilitation maintenance due to incomplete recovery.

Entities:  

Mesh:

Year:  2021        PMID: 33840181     DOI: 10.4081/monaldi.2021.1817

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  2 in total

1.  Effects of the COVID-19 Pandemic on Physical Function of Community-Dwelling People with Disabilities in Japan.

Authors:  Takayuki Kamimoto; Michiyuki Kawakami; Towa Morita; Yuta Miyazaki; Nanako Hijikata; Tomonori Akimoto; Masahiro Tsujikawa; Kaoru Honaga; Kanjiro Suzuki; Kunitsugu Kondo; Tetsuya Tsuji
Journal:  Int J Environ Res Public Health       Date:  2022-10-02       Impact factor: 4.614

2.  The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature.

Authors:  Lesley J J Soril; Ronald W Damant; Grace Y Lam; Maeve P Smith; Jason Weatherald; Jean Bourbeau; Paul Hernandez; Michael K Stickland
Journal:  Respir Med       Date:  2022-03-02       Impact factor: 3.415

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.